Literature DB >> 6774016

Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

R N Moore, J J Oppenheim, J J Farrar, C S Carter, A Waheed, R K Shadduck.   

Abstract

Murine peritoneal exudate macrophages incubated with medium conditioned by L929 cells were stimulated to produce lymphocyte-activating factor (LAF, Interleukin 1). This stimulatory activity was partially neutralized by antiserum prepared against partially purified L cell colony-stimulating factor (CSF) and comigrated upon gel filtration with the myeloproliferative activity. LAF-inducing activity of three different L cell CSF preparations, including one purified to homogeneity, was dependent upon the concentration of CSF. A minimum of 1,000 to 3,000 units of CSF activity was required to stimulate macrophagfes to produce LAF. Concanavalin A (Con A) stimulated splenic supernatants also contained CSF and LAF-inducing activities that co-eluted upon gel filtration. LAF-inducing activities co-eluting with the two Con A CSF peaks (apparent m.w. of 25,000 and 35,000) were effective at minimum dilutions containing 1,000 to 3,000 units of CSF activity correlating in potency with L cell-derived CSF. Based on these data, it is proposed that CSF, whether of L cell or lymphoid origin, not only has myeloproliferative activities but also is capable of stimulating macrophages to produce LAF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774016

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites.

Authors:  M L Sherman; B L Weber; R Datta; D W Kufe
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  The effects of interleukins and other soluble factors on T-lymphocyte colony formation.

Authors:  A Winkelstein; P L Simon; D Wood; L L Machen; R K Shadduck; A Waheed
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

7.  Immunoregulating activity of tumor-associated macrophages.

Authors:  G J Dougherty; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 8.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

9.  Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells.

Authors:  J M Molina; D T Scadden; C Amirault; A Woon; E Vannier; C A Dinarello; J E Groopman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Effects of colony-stimulating factors on proliferation and activation of synovial cells.

Authors:  M Yamamoto; M Yasuda; S Shiokawa; M Nobunaga
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.